NCT03606135已完成不适用
Etiology and Incidence Assessment of Radiographically-confirmed Community Acquired Pneumonia (CAP) in Adults ≥ 18 Years (OSPIS)
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Region Skane
- 入组人数
- 600
- 试验地点
- 1
- 主要终点
- The proportion S.pneumoniae serotypes included in PCV13 (Pneumococcal conjugate vaccine) among adults ≥18 years of age presenting with radiographically-confirmed CAP.
研究概览
简要总结
This is an epidemiological study to investigate the etiology of radiographically-confirmed community-acquired pneumonia (CAP) in adults aged ≥18 years. The main objective is to determine the proportion of which cases that is due to Streptococcus pneumoniae and the corresponding incidence and serotype distribution. The study will utilize a serotype-specific urinary antigen detection (UAD) assay.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Age ≥ 18 years.
- •Present to a study healthcare facility where treating physician clinically suspects CAP with the presence of two or more of the following signs and symptoms: Fever, Hypothermia, Chills or rigors, Pleuritic chest pain, Cough, Sputum production, Dyspnea, Tachypnea, Malaise, Abnormal auscultatory findings suggestive of pneumonia.
- •Has radiographic finding that is consistent with pneumonia.
- •Able and willing to provide urine sample.
- •Signed and dated informed consent
排除标准
- •Transferred to a study healthcare facility after already being hospitalized for 48 hours or more at any other in-patient facility.
- •Hospital acquired pneumonia.
- •Subjects who are investigational staff members and their family members, and site staff members otherwise supervised by the investigator.
- •Previous enrollment in this study within the previous 30 days.
- •Other severe acute or chronic medical or psychiatric condition or laboratory abnormality that may increase the risk associated with study participation or may interfere with the interpretation of study results and, in the judgement of the investigator, would make the subject inappropriate for entry into this study.
- •The Control Group
- •Inclusion Criteria:
- •Signed and dated informed consent.
- •Age ≥ 18 years.
- •Able and willing to provide urine sample.
- •Exclusion Criteria:
- •Subjects who are investigational staff members or relatives of those staff member or subjects who are Pfizer employees directly involved in the conduct of the study.
- •Subjects with suspicion of CAP or any other respiratory infectious disease, as well as evidence of or documented concomitant infectious disease.
- •Subjects residing in any long-term care facilities.
- •Subjects with known bronchial obstruction or history of post-obstructive pneumonia. Chronic obstructive pulmonary disease (COPD) is permissible, provided there has no been an exacerbation with 3 months prior to enrollment.
- •Subjects with primary lung cancer or another malignancy metastatic to the lungs.
- •Subjects with fever.
- •Subjects with significant immunosuppressive disease such as AIDS, leukemia, etc.
- •Subjects with either pneumococcal conjugate vaccine (PCV) and/or pneumococcal polysaccharide vaccine (PPV) administration within the past 30 days.
结局指标
主要结局
The proportion S.pneumoniae serotypes included in PCV13 (Pneumococcal conjugate vaccine) among adults ≥18 years of age presenting with radiographically-confirmed CAP.
时间窗: 10 days
The overall proportion of subjects with clinically and radiographically-confirmed CAP who have PCV13 S.pneumoniae detected by either UAD assay and/or culture.
次要结局
- The proportion of subjects with CAP and with SP+CAP who present with underlying at-risk and high-risk medical conditions(10 days)
- The S.pneumoniae serotype distribution form UAD and culture isolates.(10 days)
- The incidence rate of CAP and subjects with S.pneumoniae positive radiologically confirmed CAP (SP+CAP)(10 days)
- The differences in detection of S.pneumoniae by culture, BinaxNOW® and the UAD assay(10 days)
- Antibiotic resistance rates among isolates of S.pneumoniae(10 days)
- Validation of the UAD assay in CAP patients and compare with controls(10 days)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Prospective Radiographic and Clinical Evaluation of Surgical Treatment for Cervical DeformityCervical DeformityKyphosisScoliosisNCT01588054International Spine Study Group Foundation100
招募中
不适用
Total Ankle Replacement: Clinical and Radiological OutcomesAnkle ArthritisNCT03650010I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio1,066
尚未招募
不适用
PREVALENCE OF LOW BACK PAIN AT TERTIARY LEVECTRI/2020/11/029385Dr Nandini Sharma
已完成
不适用
Clinical Characteristics and Etiology of Infectious Optic Neuritis in ThailandDemographic data, clinical features, laboratory investigation, imaging study, clinical outcomes, etiology and associated factors to poor visual outcome of patients with infectious optic neuritis.infectious optic neuritis, parainfectious optic neuritis, demographic, clinical, investigation, treatment, imaging, clinical outcome, etiology, risk factorTCTR20211115001Chulalongkorn University20
尚未招募
Unknown
A study in newborn babies and children less than 5 years regarding low thyroid hormone problem noted since birth-number of new cases, cause and clinical dataCTRI/2024/03/063631ot applicable